MarkWide Research

Sale!

Rhinoplasty Implants Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: October, 2022
No of Pages: 159
Delivery Format: PDF+Excel

$2,950.00

Rhinoplasty Implants Market size was valued at around USD 700 million in 2020 and is projected to grow at a CAGR of over 15.9% between 2021 and 2027. Ongoing innovations associated with 3D computer-assisted techniques have improved preoperative assessment, meticulous planning, and use of 3-dimensional guided osteotomies. The rising technological advancement in aesthetic procedures has fuelled the demand for rhinoplasty implant procedures. It is a widely performed cosmetic procedure credited to the extensive benefits.

However, the lack of skilled professionals for rhinoplasty procedure may adversely affect the rhinoplasty implants market growth. The risk factors associated with these procedures may increase owing to the surgeons lack of appropriate training and required skills. The unqualified physician may put a patient at serious risk of injury. The market expansion can be hampered in emerging economies as these particular issues are rising among cosmetic surgeons. The shortage of skilled surgeons is an issue that has long been at the forefront of the medical sector.

Moreover, the regulations in these treatments are limited attributed to these procedures are rarely available through National Health Service and primarily take place in the private sector. Thus, the UK Review Committee recommended the creation of approved training schemes and accreditation qualifications for surgical and non-surgical procedures that will prove beneficial for the industry growth. In addition to this, high costs associated with the surgical procedures and unsatisfactory outcomes are set to restrict the industry expansion.

The emergence of the COVID-19 pandemic is an unprecedented health concern across the globe and has moderately impacted the market. Initially, an outbreak of SARS-CoV-2 has disrupted the supply chain and put restrictions on trade and movement of goods, thereby affecting the market. For instance, the U.S. declared a national emergency and a ban on all elective therapeutic and diagnostic procedures, as well as elective surgical in outpatient and inpatient settings.

However, the American Academy of Facial Plastic and Reconstructive Surgery reported a rapid rise in treatments and bookings during the COVID-19 pandemic for surgical rhinoplasty. This upsurge is credited to the benefits of working from home, and the flexibility to recover from treatments due to social distancing. These factors coupled with unprecedented virtual lifestyle, less travel, and masks have led to a surge in surgical procedures. As a result, the pandemic will have a significant impact on the market progression.

Rising beauty consciousness will enhance the rhinoplasty implants market revenue

Growing beauty consciousness among teenagers and adults across the globe is one of the prime factors driving the market value. Surging multiculturalism in Western countries has shifted some beauty norms that have increasingly turned up on demand for surgical and filler rhinoplasty for nose augmentation. Additionally, celebrity culture has a significant influence on beauty consciousness due to publicly admitting of having these treatments and procedures done. These cosmetic procedures and non-invasive aesthetic procedures are gaining popularity significantly. This current perception of flawless beauty becomes more unattainable that results in the female seeking cosmetic treatments to achieve perfection. With this growing willingness to undertake the financial burden for rhinoplasty, finance companies are offering various policies to ease this burden and make these procedures more attainable. Certain rhinoplasty procedures may also have significant psychological benefits for some individuals including both social and emotional. This contributes to stimulated competition and the constant emergence of product and marketing innovations.

Innovations and advent of novel technologies in surgical rhinoplasty will accelerate the industry progression

The surgical segment is anticipated to expand at 15.3% growth rate through 2027 led by multiple advantages such as positive effect on facial aesthetic, uplift the size of the nose, improve breathing, etc. Surgical rhinoplasty is one of the most popular facial plastic surgical procedure attributed to this treatment that can enhance both cosmetic and functional problems. The widely used techniques for these procedures are open and closed rhinoplasty to attain better outcomes. Closed rhinoplasty is the most preferred technique owing to it several benefits such as no visible scarring, shorter recovery period, less postoperative bruising and swelling among others.

Increasing preference for nose surgery among females will fuel the industry revenue

The rhinoplasty implants market for female segment is expected to grow at 16.1% CAGR by 2027 on account of the rising beauty consciousness, social media impact, and the desire for self-satisfaction among others. Studies confirmed a high usage of social media platforms has influenced some female patients to undergo rhinoplasty. Patient satisfaction further translates to optimistic online reviews and drives patient retention. Hence, players in the market are strongly emphasizing on social media marketing to drive the market growth significantly. Research studies showed that self-confidence identified as a significant factor in rhinoplasty implants treatment. Further, social conditions, environmental factors, and personality characteristics play a vital role in women incline to rhinoplasty implant procedures.

Numerous benefits offered by hospitals in nasal procedures will spur the industry value

The hospital segment accounted for USD 318 million in 2020 impelled by the availability of board-certified skilled professionals, quality of care, patient satisfaction, experience, etc. Easy accessibility to novel advanced technologies surge the preference for rhinoplasty implants procedures in hospitals. Iintensive post-surgical care and continuous monitoring provided in hospitals will surge the patient preference for these healthcare settings. Therefore, rising hospital admissions with nose issues and demand for rhinoplasty implants procedures along with the developments in computer simulation technologies drive the demand for rhinoplasty in these facilities.

High acceptance of technologically advanced nasal implants in the North America region will boost the regional growth

U.S. rhinoplasty implants market captured 93% of revenue share in 2020 driven by numerous factors comprising surging adoption of advanced equipment by surgeons, and rising number of rhinoplasty implants across the country. Moreover, a growing number of minimally invasive surgeries and the increasing number of product launches are contributing to the market expansion. For instance, liquid rhinoplasty is emerging as the non-surgical alternative to the conventional nose-job in the country. With the advent of dermal fillers for the nose job to change the appearance of the nose, liquid rhinoplasty is gaining substantial popularity due to its relatively low cost, convenience and short recovery time. The accessibility to proper consultation services, and stringent protocols for patient safety are further impelling the market demand.
Italy dominated the Europe market and accounted for over USD 49 million in 2020 propelled by the success of rhinoplasty implants procedures, meticulous planning, and skilled performance by doctors in the country. It is considered as one of the most preferred countries for nose job owing to medical developments, minimum recovery time, and quick & successful results among others. In Italy, rhinoplasty implants area of ??treatment is constantly developing, and modern technologies are broadly used to correct defects. The main advantages of performing these procedures in Italy are the extent of the operation according to the indications, high level of service, etc.

Strategic initiatives implemented by major market players will spur the business growth

Some of the major participants operating in the market are Implantech, Koken, Surgiform Technologies LLC, Wanhe Plastics, Stryker, W.L. Gore Associates, Allergan (AbbVie), Luminera among others. The major companies focus on strategic collaborations, mergers and partnerships in order to expand their business and launch new procedures to strengthen the procedure portfolio. Furthermore, these leaders are investing in research and development activities that allow these players to garner maximum revenue share.

Rhinoplasty implants market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:

Market, By Procedure, 2016 – 2027 (USD Million)

  • Surgical
    • Open Rhinoplasty
    • Closed Rhinoplasty
  • Non-surgical

Market, By Gender, 2016 – 2027 (USD Million)

  • Female
  • Male

Market, By End-use, 2016 – 2027 (USD Million)

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
  • Asia Pacific
    • Japan
    • China
    • India
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Columbia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Iran

Chapter 1   Methodology

1.1    Market definitions

1.2    Base estimates & working

1.3    Forecast calculations

1.4    Data validation

1.5    Data sources

1.5.1    Secondary

1.5.1.1    Paid sources

1.5.1.2    Unpaid sources

1.5.2    Primary

Chapter 2   Executive Summary

2.1    Rhinoplasty implants industry 3600 synopsis, 2016 – 2027

2.1.1    Business trends

2.1.2    Procedure trends

2.1.3    Gender trends

2.1.4    End-use trends

2.1.5    Regional trends

Chapter 3   Rhinoplasty Implants Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2016 – 2027

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Growing beauty consciousness

3.3.1.2    Technological advancement in aesthetic procedures

3.3.1.3    Rising demand for non-invasive rhinoplasty

3.3.2    Industry pitfalls & challenges

3.3.2.1    Lack of skilled professionals

3.4    Growth potential analysis

3.4.1    By procedure

3.4.2    By gender

3.4.3    By end-use

3.5    COVID-19 impact analysis

3.6    Porter’s analysis

3.7    Competitive landscape, 2020

3.7.1    Competitive matrix analysis

3.8    PESTEL analysis

Chapter 4   Rhinoplasty Implants Market, By Procedure

4.1    Key segment trends

4.2    Surgical

4.2.1    Market size, by region, 2016 – 2027 (USD Million)

4.2.2    Open rhinoplasty

4.2.2.1    Market size, by region, 2016 – 2027 (USD Million)

4.2.3    Closed rhinoplasty

4.2.3.1    Market size, by region, 2016 – 2027 (USD Million)

4.3    Non-surgical

4.3.1    Market size, by region, 2016 -2027 (USD Million)

Chapter 5   Rhinoplasty Implants Market, By Gender

5.1    Key segment trends

5.2    Female

5.2.1    Market size, by region, 2016– 2027 (USD Million)

5.3    Male

5.3.1    Market size, by region, 2016– 2027 (USD Million)

Chapter 6   Rhinoplasty Implants Market, By End-use

6.1    Key segment trends

6.2    Hospitals

6.2.1    Market size, by region, 2016– 2027 (USD Million)

6.3    Ambulatory Surgical Centers

6.3.1    Market size, by region, 2016– 2027 (USD Million)

6.4    Others

6.4.1    Market size, by region, 2016– 2027 (USD Million)

Chapter 7   Rhinoplasty Implants Market, By Region

7.1    Key regional trends

7.2    North America

7.2.1    Market size, by country, 2016 – 2027 (USD Million)

7.2.2    Market size, by procedure, 2016 – 2027 (USD Million)

7.2.2.1    Market size, by surgical, 2016 – 2027 (USD Million)

7.2.3    Market size, by gender, 2016 – 2027 (USD Million)

7.2.4    Market size, by end-use, 2016 – 2027 (USD Million)

7.2.5    U.S.

7.2.5.1    Market size, by procedure, 2016 – 2027 (USD Million)

7.2.5.1.1    Market size, by surgical, 2016 – 2027 (USD Million)

7.2.5.2    Market size, by gender, 2016 – 2027 (USD Million)

7.2.5.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.2.6    Canada

7.2.6.1    Market size, by procedure, 2016 – 2027 (USD Million)

7.2.6.1.1    Market size, by surgical, 2016 – 2027 (USD Million)

7.2.6.2    Market size, by gender, 2016 – 2027 (USD Million)

7.2.6.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.3    Europe

7.3.1    Market size, by country, 2016 – 2027 (USD Million)

7.3.2    Market size, by procedure, 2016 – 2027 (USD Million)

7.3.2.1    Market size, by surgical, 2016 – 2027 (USD Million)

7.3.3    Market size, by gender, 2016 – 2027 (USD Million)

7.3.4    Market size, by end-use, 2016 – 2027 (USD Million)

7.3.5    Germany

7.3.5.1    Market size, by procedure, 2016 – 2027 (USD Million)

7.3.5.1.1    Market size, by surgical, 2016 – 2027 (USD Million)

7.3.5.2    Market size, by gender, 2016 – 2027 (USD Million)

7.3.5.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.3.6    UK

7.3.6.1    Market size, by procedure, 2016 – 2027 (USD Million)

7.3.6.1.1    Market size, by surgical, 2016 – 2027 (USD Million)

7.3.6.2    Market size, by gender, 2016 – 2027 (USD Million)

7.3.6.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.3.7    France

7.3.7.1    Market size, by procedure, 2016 – 2027 (USD Million)

7.3.7.1.1    Market size, by surgical, 2016 – 2027 (USD Million)

7.3.7.2    Market size, by gender, 2016 – 2027 (USD Million)

7.3.7.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.3.8    Spain

7.3.8.1    Market size, by procedure, 2016 – 2027 (USD Million)

7.3.8.1.1    Market size, by surgical, 2016 – 2027 (USD Million)

7.3.8.2    Market size, by gender, 2016 – 2027 (USD Million)

7.3.8.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.3.9    Italy

7.3.9.1    Market size, by procedure, 2016 – 2027 (USD Million)

7.3.9.1.1    Market size, by surgical, 2016 – 2027 (USD Million)

7.3.9.2    Market size, by gender, 2016 – 2027 (USD Million)

7.3.9.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.4    Asia Pacific

7.4.1    Market size, by country, 2016 – 2027 (USD Million)

7.4.2    Market size, by procedure, 2016 – 2027 (USD Million)

7.4.2.1    Market size, by surgical, 2016 – 2027 (USD Million)

7.4.3    Market size, by gender, 2016 – 2027 (USD Million)

7.4.4    Market size, by end-use, 2016 – 2027 (USD Million)

7.4.5    China

7.4.5.1    Market size, by procedure, 2016 – 2027 (USD Million)

7.4.5.1.1    Market size, by surgical, 2016 – 2027 (USD Million)

7.4.5.2    Market size, by gender, 2016 – 2027 (USD Million)

7.4.5.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.4.6    Japan

7.4.6.1    Market size, by procedure, 2016 – 2027 (USD Million)

7.4.6.1.1    Market size, by surgical, 2016 – 2027 (USD Million)

7.4.6.2    Market size, by gender, 2016 – 2027 (USD Million)

7.4.6.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.4.7    India

7.4.7.1    Market size, by procedure, 2016 – 2027 (USD Million)

7.4.7.1.1    Market size, by surgical, 2016 – 2027 (USD Million)

7.4.7.2    Market size, by gender, 2016 – 2027 (USD Million)

7.4.7.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.4.8    Thailand

7.4.8.1    Market size, by procedure, 2016 – 2027 (USD Million)

7.4.8.1.1    Market size, by surgical, 2016 – 2027 (USD Million)

7.4.8.2    Market size, by gender, 2016 – 2027 (USD Million)

7.4.8.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.4.9    South Korea

7.4.9.1    Market size, by procedure, 2016 – 2027 (USD Million)

7.4.9.1.1    Market size, by surgical, 2016 – 2027 (USD Million)

7.4.9.2    Market size, by gender, 2016 – 2027 (USD Million)

7.4.9.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.5    Latin America

7.5.1    Market size, by country, 2016 – 2027 (USD Million)

7.5.2    Market size, by procedure, 2016 – 2027 (USD Million)

7.5.2.1    Market size, by surgical, 2016 – 2027 (USD Million)

7.5.3    Market size, by gender, 2016 – 2027 (USD Million)

7.5.4    Market size, by end-use, 2016 – 2027 (USD Million)

7.5.5    Brazil

7.5.5.1    Market size, by procedure, 2016 – 2027 (USD Million)

7.5.5.1.1    Market size, by surgical, 2016 – 2027 (USD Million)

7.5.5.2    Market size, by gender, 2016 – 2027 (USD Million)

7.5.5.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.5.6    Mexico

7.5.6.1    Market size, by procedure, 2016 – 2027 (USD Million)

7.5.6.1.1    Market size, by surgical, 2016 – 2027 (USD Million)

7.5.6.2    Market size, by gender, 2016 – 2027 (USD Million)

7.5.6.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.5.7    Columbia

7.5.7.1    Market size, by procedure, 2016 – 2027 (USD Million)

7.5.7.1.1    Market size, by surgical, 2016 – 2027 (USD Million)

7.5.7.2    Market size, by gender, 2016 – 2027 (USD Million)

7.5.7.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.6    MEA

7.6.1    Market size, by country, 2016 – 2027 (USD Million)

7.6.2    Market size, by procedure, 2016 – 2027 (USD Million)

7.6.2.1    Market size, by surgical, 2016 – 2027 (USD Million)

7.6.3    Market size, by gender, 2016 – 2027 (USD Million)

7.6.4    Market size, by end-use, 2016 – 2027 (USD Million)

7.6.5    South Africa

7.6.5.1    Market size, by procedure, 2016 – 2027 (USD Million)

7.6.5.1.1    Market size, by surgical, 2016 – 2027 (USD Million)

7.6.5.2    Market size, by gender, 2016 – 2027 (USD Million)

7.6.5.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.6.6    Saudi Arabia

7.6.6.1    Market size, by procedure, 2016 – 2027 (USD Million)

7.6.6.1.1    Market size, by surgical, 2016 – 2027 (USD Million)

7.6.6.2    Market size, by gender, 2016 – 2027 (USD Million)

7.6.6.3    Market size, by end-use, 2016 – 2027 (USD Million)

7.6.7    Iran

7.6.7.1    Market size, by procedure, 2016 – 2027 (USD Million)

7.6.7.1.1    Market size, by surgical, 2016 – 2027 (USD Million)

7.6.7.2    Market size, by gender, 2016 – 2027 (USD Million)

7.6.7.3    Market size, by end-use, 2016 – 2027 (USD Million)

Chapter 8   Company Profiles

8.1    Competitive dashboard, 2020

8.2    Implantech

8.2.1    Business overview

8.2.2    Financial data

8.2.3    Product landscape

8.2.4    Strategic Outlook

8.2.5    SWOT analysis

8.3    Koken

8.3.1    Business overview

8.3.2    Financial data

8.3.3    Product landscape

8.3.4    Strategic Outlook

8.3.5    SWOT analysis

8.4    Surgiform Technologies LLC

8.4.1    Business overview

8.4.2    Financial data

8.4.3    Product landscape

8.4.4    Strategic Outlook

8.4.5    SWOT analysis

8.5    Wanhe Plastics

8.5.1    Business overview

8.5.2    Financial data

8.5.3    Product landscape

8.5.4    Strategic Outlook

8.5.5    SWOT analysis

8.6    Stryker

8.6.1    Business overview

8.6.2    Financial data

8.6.3    Product landscape

8.6.4    Strategic Outlook

8.6.5    SWOT analysis

8.7    W L Gore Associates

8.7.1    Business overview

8.7.2    Financial data

8.7.3    Product landscape

8.7.4    Strategic Outlook

8.7.5    SWOT analysis

8.8    Galderma

8.8.1    Business overview

8.8.2    Financial data

8.8.3    Product landscape

8.8.4    Strategic Outlook

8.8.5    SWOT analysis

8.9    Anika Therapeutics

8.9.1    Business overview

8.9.2    Financial data

8.9.3    Product landscape

8.9.4    Strategic Outlook

8.9.5    SWOT analysis

8.10    Luminera

8.10.1    Business overview

8.10.2    Financial data

8.10.3    Product landscape

8.10.4    Strategic Outlook

8.10.5    SWOT analysis

8.11    Croma Pharma

8.11.1    Business overview

8.11.2    Financial data

8.11.3    Product landscape

8.11.4    Strategic Outlook

8.11.5    SWOT analysis

8.12    Prollenium Medical Technologies

8.12.1    Business overview

8.12.2    Financial data

8.12.3    Product landscape

8.12.4    Strategic Outlook

8.12.5    SWOT analysis

8.13    Sinclair Pharma

8.13.1    Business overview

8.13.2    Financial data

8.13.3    Product landscape

8.13.4    Strategic Outlook

8.13.5    SWOT analysis

Data Tables

TABLE 1  Global rhinoplasty implants market size, 2016 – 2020, (USD Million)

TABLE 2  Global rhinoplasty implants market size, 2021 – 2027, (USD Million)

TABLE 3  Global rhinoplasty implants market size, by procedure, 2016 – 2020 (USD Million)

TABLE 4  Global rhinoplasty implants market size, by procedure, 2021 – 2027 (USD Million)

TABLE 5  Global rhinoplasty implants market size, by gender, 2016 – 2020 (USD Million)

TABLE 6  Global rhinoplasty implants market size, by gender, 2021 – 2027 (USD Million)

TABLE 8    Global rhinoplasty implants market size, by end-use, 2016 – 2020 (USD Million)

TABLE 9    Global rhinoplasty implants market size, by end-use, 2021 – 2027 (USD Million)

TABLE 10     Global rhinoplasty implants market size, by region, 2016 – 2020 (USD Million)

TABLE 11     Global rhinoplasty implants market size, by region, 2021 – 2027 (USD Million)

TABLE 12     Industry impact forces

TABLE 13     Surgical market size, by region, 2016 – 2020 (USD Million)

TABLE 14     Surgical market size, by region, 2021 – 2027 (USD Million)

TABLE 15     Open rhinoplasty market size, by region, 2016 – 2020 (USD Million)

TABLE 16     Open rhinoplasty market size, by region, 2021 – 2027 (USD Million)

TABLE 17     Closed rhinoplasty market size, by region, 2016 – 2020 (USD Million)

TABLE 18    Closed rhinoplasty market size, by region, 2021 – 2027 (USD Million)

TABLE 19     Non-surgical market size, by region, 2016 – 2020 (USD Million)

TABLE 20     Non-surgical market size, by region, 2021 – 2027 (USD Million)

TABLE 21     Female market size, by region, 2016 – 2020 (USD Million)

TABLE 22     Female market size, by region, 2021 – 2027 (USD Million)

TABLE 23     Male market size, by region, 2016 – 2020 (USD Million)

TABLE 24     Male market size, by region, 2021 – 2027 (USD Million)

TABLE 25   Hospitals market size, by region, 2016 – 2020 (USD Million)

TABLE 26   Hospitals market size, by region, 2021 – 2027 (USD Million)

TABLE 27   Ambulatory surgical centers market size, by region, 2016 – 2020 (USD Million)

TABLE 29   Ambulatory surgical centers market size, by region, 2021 – 2027 (USD Million)

TABLE 30       Others market size, by region, 2016 – 2020 (USD Million)

TABLE 31       Others market size, by region, 2021 – 2027 (USD Million)

TABLE 32       North America market size, by country, 2016 – 2020 (USD Million)

TABLE 33       North America market size, by country, 2021 – 2027 (USD Million)

TABLE 34       North America market size, by procedure, 2016 – 2020 (USD Million)

TABLE 35       North America market size, by procedure, 2021 – 2027 (USD Million)

TABLE 36       North America market size, by surgical, 2016 – 2020 (USD Million)

TABLE 37       North America market size, by surgical, 2021 – 2027 (USD Million)

TABLE 38       North America market size, by gender, 2016 – 2020 (USD Million)

TABLE 39       North America market size, by gender, 2021 – 2027 (USD Million)

TABLE 40       North America market size, by end-use, 2016 – 2020 (USD Million)

TABLE 41       North America market size, by end-use, 2021 – 2027 (USD Million)

TABLE 42       U.S. market size, by procedure, 2016 – 2020 (USD Million)

TABLE 43       U.S. market size, by procedure, 2021 – 2027 (USD Million)

TABLE 44       U.S. market size, by surgical, 2016 – 2020 (USD Million)

TABLE 45       U.S. market size, by surgical, 2021 – 2027 (USD Million)

TABLE 46       U.S. market size, by gender, 2016 – 2020 (USD Million)

TABLE 47       U.S. market size, by gender, 2021 – 2027 (USD Million)

TABLE 48       U.S. market size, by end-use, 2016 – 2020 (USD Million)

TABLE 49       U.S. market size, by end-use, 2021 – 2027 (USD Million)

TABLE 50       Canada market size, by procedure, 2016 – 2020 (USD Million)

TABLE 51       Canada market size, by procedure, 2021 – 2027 (USD Million)

TABLE 52      Canada market size, by surgical, 2016 – 2020 (USD Million)

TABLE 53       Canada market size, by surgical, 2021 – 2027 (USD Million)

TABLE 54       Canada market size, by gender, 2016 – 2020 (USD Million)

TABLE 55       Canada market size, by gender, 2021 – 2027 (USD Million)

TABLE 56       Canada market size, by end-use, 2016 – 2020 (USD Million)

TABLE 57       Canada market size, by end-use, 2021 – 2027 (USD Million)

TABLE 58       Europe market size, by country, 2016 – 2020 (USD Million)

TABLE 59       Europe market size, by country, 2021 – 2027 (USD Million)

TABLE 60       Europe market size, by procedure, 2016 – 2020 (USD Million)

TABLE 61       Europe market size, by procedure, 2021 – 2027 (USD Million)

TABLE 62       Europe market size, by surgical, 2016 – 2020 (USD Million)

TABLE 63       Europe market size, by surgical, 2021 – 2027 (USD Million)

TABLE 64       Europe market size, by gender, 2016 – 2020 (USD Million)

TABLE 65       Europe market size, by gender, 2021 – 2027 (USD Million)

TABLE 66       Europe market size, by end-use, 2016 – 2020 (USD Million)

TABLE 67       Europe market size, by end-use, 2021 – 2027 (USD Million)

TABLE 68       Germany market size, by procedure, 2016 – 2020 (USD Million)

TABLE 69       Germany market size, by procedure, 2021 – 2027 (USD Million)

TABLE 70       Germany market size, by surgical, 2016 – 2020 (USD Million)

TABLE 71       Germany market size, by surgical, 2021 – 2027 (USD Million)

TABLE 72       Germany market size, by gender, 2016 – 2020 (USD Million)

TABLE 73       Germany market size, by gender, 2021 – 2027 (USD Million)

TABLE 74       Germany market size, by end-use, 2016 – 2020 (USD Million)

TABLE 75       Germany market size, by end-use, 2021 – 2027 (USD Million)

TABLE 76       UK market size, by procedure, 2016 – 2020 (USD Million)

TABLE 77       UK market size, by procedure, 2021 – 2027 (USD Million)

TABLE 78       UK market size, by surgical, 2016 – 2020 (USD Million)

TABLE 79       UK market size, by surgical, 2021 – 2027 (USD Million)

TABLE 80       UK market size, by gender, 2016 – 2020 (USD Million)

TABLE 81       UK market size, by gender, 2021 – 2027 (USD Million)

TABLE 82       UK market size, by end-use, 2016 – 2020 (USD Million)

TABLE 83       UK market size, by end-use, 2021 – 2027 (USD Million)

TABLE 84       France market size, by procedure, 2016 – 2020 (USD Million)

TABLE 85       France market size, by procedure, 2021 – 2027 (USD Million)

TABLE 86       France market size, by surgical, 2016 – 2020 (USD Million)

TABLE 87       France market size, by surgical, 2021 – 2027 (USD Million)

TABLE 88       France market size, by gender, 2016 – 2020 (USD Million)

TABLE 89       France market size, by gender, 2021 – 2027 (USD Million)

TABLE 90       France market size, by end-use, 2016 – 2020 (USD Million)

TABLE 91       France market size, by end-use, 2021 – 2027 (USD Million)

TABLE 92       Spain market size, by procedure, 2016 – 2020 (USD Million)

TABLE 93       Spain market size, by procedure, 2021 – 2027 (USD Million)

TABLE 94       Spain market size, by surgical, 2016 – 2020 (USD Million)

TABLE 95       Spain market size, by surgical, 2021 – 2027 (USD Million)

TABLE 96       Spain market size, by gender, 2016 – 2020 (USD Million)

TABLE 97       Spain market size, by gender, 2021 – 2027 (USD Million)

TABLE 98       Spain market size, by end-use, 2016 – 2020 (USD Million)

TABLE 99       Spain market size, by end-use, 2021 – 2027 (USD Million)

TABLE 100    Italy market size, by procedure, 2016 – 2020 (USD Million)

TABLE 101    Italy market size, by procedure, 2021 – 2027 (USD Million)

TABLE 102    Italy market size, by surgical, 2016 – 2020 (USD Million)

TABLE 103    Italy market size, by surgical, 2021 – 2027 (USD Million)

TABLE 104    Italy market size, by gender, 2016 – 2020 (USD Million)

TABLE 105    Italy market size, by gender, 2021 – 2027 (USD Million)

TABLE 106    Italy market size, by end-use, 2016 – 2020 (USD Million)

TABLE 107    Italy market size, by end-use, 2021 – 2027 (USD Million)

TABLE 108    Asia Pacific market size, by country, 2016 – 2020 (USD Million)

TABLE 109    Asia Pacific market size, by country, 2021 – 2027 (USD Million)

TABLE 110    Asia Pacific market size, by procedure, 2016 – 2020 (USD Million)

TABLE 111    Asia Pacific market size, by procedure, 2021 – 2027 (USD Million)

TABLE 112    Asia Pacific market size, by surgical, 2016 – 2020 (USD Million)

TABLE 113    Asia Pacific market size, by surgical, 2021 – 2027 (USD Million)

TABLE 114    Asia Pacific market size, by gender, 2016 – 2020 (USD Million)

TABLE 115    Asia Pacific market size, by gender, 2021 – 2027 (USD Million)

TABLE 116    Asia Pacific market size, by end-use, 2016 – 2020 (USD Million)

TABLE 117    Asia Pacific market size, by end-use, 2021 – 2027 (USD Million)

TABLE 118    China market size, by procedure, 2016 – 2020 (USD Million)

TABLE 119    China market size, by procedure, 2021 – 2027 (USD Million)

TABLE 120    China market size, by surgical, 2016 – 2020 (USD Million)

TABLE 121    China market size, by surgical, 2021 – 2027 (USD Million)

TABLE 122    China market size, by gender, 2016 – 2020 (USD Million)

TABLE 123    China market size, by gender, 2021 – 2027 (USD Million)

TABLE 124    China market size, by end-use, 2016 – 2020 (USD Million)

TABLE 125    China market size, by end-use, 2021 – 2027 (USD Million)

TABLE 126    Japan market size, by procedure, 2016 – 2020 (USD Million)

TABLE 127    Japan market size, by procedure, 2021 – 2027 (USD Million)

TABLE 128    Japan market size, by surgical, 2016 – 2020 (USD Million)

TABLE 129    Japan market size, by surgical, 2021 – 2027 (USD Million)

TABLE 130    Japan market size, by gender, 2016 – 2020 (USD Million)

TABLE 131    Japan market size, by gender, 2021 – 2027 (USD Million)

TABLE 132    Japan market size, by end-use, 2016 – 2020 (USD Million)

TABLE 133    Japan market size, by end-use, 2021 – 2027 (USD Million)

TABLE 134    India market size, by procedure, 2016 – 2020 (USD Million)

TABLE 135    India market size, by procedure, 2021 – 2027 (USD Million)

TABLE 136    India market size, by surgical, 2016 – 2020 (USD Million)

TABLE 137    India market size, by surgical, 2021 – 2027 (USD Million)

TABLE 138    India market size, by gender, 2016 – 2020 (USD Million)

TABLE 139    India market size, by gender, 2021 – 2027 (USD Million)

TABLE 140    India market size, by end-use, 2016 – 2020 (USD Million)

TABLE 141    India market size, by end-use, 2021 – 2027 (USD Million)

TABLE 142    Thailand market size, by procedure, 2016 – 2020 (USD Million)

TABLE 143    Thailand market size, by procedure, 2021 – 2027 (USD Million)

TABLE 144    Thailand market size, by surgical, 2016 – 2020 (USD Million)

TABLE 145    Thailand market size, by surgical, 2021 – 2027 (USD Million)

TABLE 146    Thailand market size, by gender, 2016 – 2020 (USD Million)

TABLE 147    Thailand market size, by gender, 2021 – 2027 (USD Million)

TABLE 148    Thailand market size, by end-use, 2016 – 2020 (USD Million)

TABLE 149    Thailand market size, by end-use, 2021 – 2027 (USD Million)

TABLE 150    South Korea market size, by procedure, 2016 – 2020 (USD Million)

TABLE 151    South Korea market size, by procedure, 2021 – 2027 (USD Million)

TABLE 152    South Korea market size, by surgical, 2016 – 2020 (USD Million)

TABLE

Market, By Procedure, 2016 – 2027 (USD Million)

  • Surgical
    • Open Rhinoplasty
    • Closed Rhinoplasty
  • Non-surgical

Market, By Gender, 2016 – 2027 (USD Million)

  • Female
  • Male

Market, By End-use, 2016 – 2027 (USD Million)

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Implantech, Koken, Surgiform Technologies LLC, Wanhe Plastics, Stryker, W.L. Gore Associates, Allergan (AbbVie), Luminera among others.

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF